Voyager Therapeutics Inc (VYGR)
7.91
+0.05
(+0.64%)
USD |
NASDAQ |
Jun 28, 16:00
7.89
-0.02
(-0.25%)
After-Hours: 20:00
Voyager Therapeutics Accounts Receivable (Quarterly): 0.837M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.837M |
December 31, 2023 | 80.15M |
September 30, 2023 | |
June 30, 2023 | |
March 31, 2023 | 25.00M |
December 31, 2022 | 0.00 |
September 30, 2022 | 10.00M |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 |
Date | Value |
---|---|
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | 11.73M |
June 30, 2019 | 8.242M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2022
80.15M
Maximum
Dec 2023
19.42M
Average
10.00M
Median
Sep 2022
Accounts Receivable (Quarterly) Benchmarks
Ligand Pharmaceuticals Inc | 28.44M |
Durect Corp | 1.02M |
Stereotaxis Inc | 3.953M |
Agios Pharmaceuticals Inc | 3.453M |
Cara Therapeutics Inc | 1.718M |